Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotonya M Carr

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Translational Science|December 31, 2024
Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systemsAnna O Basile, Anurag Verma, Leigh Anne Tang, et al.
Alcohol (Fayetteville, N.Y.)|May 1, 2020
Summary of the 2019 alcohol and immunology research interest group (AIRIG) meeting: Alcohol-mediated mechanisms of multiple organ injuryRachel H McMahan, Majid Afshar, Angela M Amedee, et al.
Hepatology (Baltimore, Md.)|September 23, 2020
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter ExperienceAtoosa Rabiee, Brett Sadowski, Nia Adeniji, et al.
Eclinicalmedicine|August 21, 2023
Large-scale identification of undiagnosed hepatic steatosis using natural language processingCarolin V Schneider, Tang Li, David Zhang, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
A missense variant in human perilipin 2 (<i>PLIN2</i> Ser251Pro) reduces hepatic steatosis in miceEleonora Scorletti, Yedidya Saiman, Sookyoung Jeon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center StudyDonghee Kim, Nia Adeniji, Nyann Latt, et al.
Plos One|August 26, 2020
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran programMarina Serper, Marijana Vujkovic, David E Kaplan, et al.
Hepatology Communications|January 12, 2023
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD studyElizabeth S Aby, Ghady Moafa, Nyan Latt, et al.
Nature Communications|May 11, 2021
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymesRaha Pazoki, Marijana Vujkovic, Joshua Elliott, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Translational Science|December 31, 2024
Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systemsAnna O Basile, Anurag Verma, Leigh Anne Tang, et al.
Alcohol (Fayetteville, N.Y.)|May 1, 2020
Summary of the 2019 alcohol and immunology research interest group (AIRIG) meeting: Alcohol-mediated mechanisms of multiple organ injuryRachel H McMahan, Majid Afshar, Angela M Amedee, et al.
Hepatology (Baltimore, Md.)|September 23, 2020
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter ExperienceAtoosa Rabiee, Brett Sadowski, Nia Adeniji, et al.
Eclinicalmedicine|August 21, 2023
Large-scale identification of undiagnosed hepatic steatosis using natural language processingCarolin V Schneider, Tang Li, David Zhang, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
A missense variant in human perilipin 2 (<i>PLIN2</i> Ser251Pro) reduces hepatic steatosis in miceEleonora Scorletti, Yedidya Saiman, Sookyoung Jeon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center StudyDonghee Kim, Nia Adeniji, Nyann Latt, et al.
Plos One|August 26, 2020
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran programMarina Serper, Marijana Vujkovic, David E Kaplan, et al.
Hepatology Communications|January 12, 2023
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD studyElizabeth S Aby, Ghady Moafa, Nyan Latt, et al.
Nature Communications|May 11, 2021
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymesRaha Pazoki, Marijana Vujkovic, Joshua Elliott, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
Pageof 7